Hemostasis and Tissue Sealing Agents Market Research Report: by Product (Topical hemostats, Mechanical), End User (Hospital, Ambulatory Centers) - Forecast Till 2027
ID: MRFR/HC/6090-HCR | February 2021 | Region: Global | 90 pages
Hemostasis and Tissue Sealing Agents Market Scenario
Hemostasis and Tissue Sealing Agents Market is expected to grow significantly and is projected to grow at a CAGR of 8.6% over the forecast period. Hemostats, adhesives and sealants are useful aides to modern surgical procedures. Topical hemostats are utilized intraoperatively first and postoperatively to a reduce extent. These products can be utilized to diffuse raw surface bleeding, bone bleeding, oozing venous type bleeds, and needle-opening bleeding. There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Surgical procedures are medical interventions involving an incision with instruments usually performed in an operating theatre and normally involving various medical devices such as catheters and tubes. For instance, according to the Center for Diseases Control and Prevention, approximately 46.5 million surgical procedures are performed every year in the U.S. Additionally, according to the NHS, surgery is the most important treatment offered by the NHS in secondary care within the UK. Furthermore, in 2015, NHS estimated that there were around 4.7 million surgical admissions in England, out of which 1.3 million procedures were for general surgery and around 1.2 million procedures were for trauma and orthopedics. These high surgical procedure numbers lead to rising need for hemostasis and tissue sealing agents which reduces the risk during surgical procedures. However, factors such as increasing advancement minimally invasive procedures, lack of reimbursement for these products is hampering the growth of the market.
Hemostasis and Tissue Sealing Agents Market Segmentation
The hemostasis and tissue sealing agents market has been segmented into product, and end user.
By product, the market has been segmented into topical hemostats, and adhesive & tissue sealant. Furthermore, topical hemostats is divided into Active, mechanical (collagen based hemostats, cellulose based hemostats, gelatin based hemostats, polysaccharide based hemostats) Flowable. Adhesive & tissue sealant is further segmented into synthetic, natural, and adhesion barrier.
Further on the basis of end user the market is bifurcated into hospitals, ambulatory centers and others
The Hemostasis and tissue sealing agents market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The diagnostics imaging workstations market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.
The European Hemostasis and tissue sealing agents market has been segmented into Western Europe and Eastern Europe. The Western Europe diagnostics imaging workstations market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The diagnostics imaging workstations market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The diagnostics imaging services market in the Middle East & Africa has been segmented into the Middle East and Africa.
Hemostasis and Tissue Sealing Agents Market Key players
Johnson & Johnson, Cryolife, Inc., Baxter International, Inc, Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical, Inc., Pfizer, Inc, Medtronic plc, B. Braun Melsungen AG, MIL Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc
Hemostasis and Tissue Sealing Agents Regional Market Summary
Global Hemostasis and tissue sealing agents Systems Share (%), by Region, 2017
Source: White Papers, Company Presentations, Annual Reports
Geographically, the Americas is anticipated to dominate the hemostasis and tissue sealing agents market owing to the high clinical R&D budgets by both government as well as public and private organizations, presence of major manufacturers for the products, high number of surgical procedures and various others. Europe is expected to hold the second largest position in the hemostasis and tissue sealing agents market. The Hemostasis and tissue sealing agents market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increased medical tourism for surgical procedures, increasing healthcare expenditure in developing countries and various others. The Middle East & Africa has the lowest share of the hemostasis and tissue sealing agents market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.
Hemostasis and Tissue Sealing Agents Market, by Product
- Topical hemostats
- Collagen Based Hemostats
- Cellulose Based Hemostats
- Gelatin Based Hemostats
- Polysaccharide Based Hemostats
- Active
- Mechanical
- Flowable
- Adhesive & tissue sealant
- Synthetic
- Natural
- Adhesion barrier
Hemostasis and Tissue Sealing Agents Market, by End User
- Hospitals
- Ambulatory Centers
- Others
Hemostasis and Tissue Sealing Agents Market, by Region
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
- Middle East
- Africa
Company Profiles
- Johnson & Johnson
- Cryolife, Inc.
- Baxter International, Inc
- Ethicon LLC
- Integra Lifesciences Corporation
- Becton, Dickinson & Company
- Cohera Medical, Inc.
- Pfizer, Inc
- Medtronic plc
- Braun Melsungen AG
- MIL Laboratories Pvt. Ltd
- Advanced Medical Solutions Group Plc
- Others
Intended Audience
- Hemostasis and Tissue Sealing Agents manufacturers and suppliers
- Research and Development (R&D) Companies
- Government and Independent Regulatory Authorities
- Market Research and Consulting Usage Modes
- Academic Institutes and Universities
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 8.6% (2018-2023) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, and End user |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Johnson & Johnson, Cryolife, Inc., Baxter International, Inc, Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson & Company, Cohera Medical, Inc., Pfizer, Inc, Medtronic plc, B. Braun Melsungen AG, MIL Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc |
| Key Market Opportunities | New product launches and R&D Amongst major key Players |
| Key Market Drivers | Large number of surgical procedures |
Frequently Asked Questions (FAQ) :
The hemostasis and tissue sealing agents market is expected to exhibit a solid 8.6% CAGR over the forecast period.
The increasing demand for minimally invasive surgical procedures is likely to be a key restraint on the hemostasis and tissue sealing agents market.
The Americas is the dominant regional market.
Leading players in the hemostasis and tissue sealing agents market include Cryolife, Johnson & Johnson, Becton Dickinson and Company, Pfizer, Medtronic, and Baxter, among others.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
Chapter 6. Global Hemostasis and tissue sealing agents Market , by Product
6.1 Introduction
6.2 Topical hemostats
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.1 Active
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2 Mechanical
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2.1 Collagen Based Hemostats
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2.2 Cellulose Based Hemostats
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2.3 Gelatin Based Hemostats
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.2.4 Polysaccharide Based Hemostats
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.2.3 Flowable
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3 Adhesive & tissue sealant
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.1 Synthetic
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.2 Natural
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3.3 Adhesion barrier
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 7. Global Hemostasis and tissue sealing agents Market , by End User
7.1 Introduction
7.2 Hospitals
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3 Ambulatory Centers
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.4 Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 8. Global Hemostasis and tissue sealing agents Market , by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 Latin America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Introduction
9.2 Market Share Analysis
9.3 Key Development & Strategies
Chapter 10. Company Profiles
10.1 Johnson & Johnson
10.1.1 Company Overview
10.1.2 Treatment Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Cryolife, Inc.
10.2.1 Company Overview
10.2.2 Treatment Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Baxter International, Inc
10.3.1 Company Overview
10.3.2 Treatment Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 Biomet Inc
10.4.1 Company Overview
10.4.2 Treatment Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 Integra Lifesciences Corporation
10.5.1 Company Overview
10.5.2 Treatment Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 Becton, Dickinson & Company
10.6.1 Company Overview
10.6.2 Treatment Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Cohera Medical, Inc.
10.7.1 Overview
10.7.2 Treatment Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
12.8 Pfizer, Inc
10.8.1 Overview
10.8.2 Treatment Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Medtronic plc.
10.9.1 Overview
10.9.2 Treatment Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 B. Braun Melsungen AG
10.10.1 Overview
10.10.2 Treatment Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.11 MIL Laboratories Pvt. Ltd.
10.11.1 Overview
10.11.2 Treatment Overview
10.11.3 Financials
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.12 Advanced Medical Solutions Group Plc
10.12.1 Overview
10.12.2 Treatment Overview
10.12.3 Financials
10.12.4 Key Developments
10.12.5 SWOT Analysis
10.13 Others
Chapter 11. Appendix
LIST OF TABLES
Table 1 Global Hemostasis and tissue sealing agents Market Synopsis, 2020–2027
Table 2 Global Hemostasis and tissue sealing agents Market Estimates and Forecast, 2020–2027 (USD Million)
Table 3 Global Hemostasis and tissue sealing agents Market , by Region, 2020–2027 (USD Million)
Table 4 Global Hemostasis and tissue sealing agents Market , by Product, 2020–2027 (USD Million)
Table 5 Global Hemostasis and tissue sealing agents Market , by End User, 2020–2027 (USD Million)
Table 6 North America: Hemostasis and tissue sealing agents Market , by Product, 2020–2027 (USD Million)
Table 7 North America: Hemostasis and tissue sealing agents Market , by End User, 2020–2027 (USD Million)
Table 8 US: Hemostasis and tissue sealing agents Market , by Product, 2020–2027 (USD Million)
Table 9 US: Hemostasis and tissue sealing agents Market , by End User, 2020–2027 (USD Million)
Table 10 Canada: Hemostasis and tissue sealing agents Market , by Product, 2020–2027 (USD Million)
Table 11 Canada: Hemostasis and tissue sealing agents Market , by End User, 2020–2027 (USD Million)
Table 12 Latin America: Hemostasis and tissue sealing agents Market , by Product, 2020–2027 (USD Million)
Table 13 Latin America: Hemostasis and tissue sealing agents Market , by End User, 2020–2027 (USD Million)
Table 14 Europe: Hemostasis and tissue sealing agents Market , by Product, 2020–2027 (USD Million)
Table 15 Europe: Hemostasis and tissue sealing agents Market , by End User, 2020–2027 (USD Million)
Table 16 Western Europe: Hemostasis and tissue sealing agents Market , by Product, 2020–2027 (USD Million)
Table 17 Western Europe: Hemostasis and tissue sealing agents Market , by End User, 2020–2027 (USD Million)
Table 18 Eastern Europe: Hemostasis and tissue sealing agents Market , by Product, 2020–2027 (USD Million)
Table 19 Eastern Europe: Hemostasis and tissue sealing agents Market , by End User, 2020–2027 (USD Million)
Table 20 Asia-Pacific: Hemostasis and tissue sealing agents Market , by Product, 2020–2027 (USD Million)
Table 21 Asia-Pacific: Hemostasis and tissue sealing agents Market , by End User, 2020–2027 (USD Million)
Table 22 Middle East & Africa: Hemostasis and tissue sealing agents Market , by Product, 2020–2027 (USD Million)
Table 23 Middle East & Africa: Hemostasis and tissue sealing agents Market , by End User, 2020–2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Hemostasis and tissue sealing agents Market
Figure 3 Segmentation Market Dynamics for Global Hemostasis and tissue sealing agents Market
Figure 4 Global Hemostasis and tissue sealing agents Market Share, by Product, 2020
Figure 5 Global Hemostasis and tissue sealing agents Market Share, by End User, 2020
Figure 6 Global Hemostasis and tissue sealing agents Market Share, by Region, 2020
Figure 7 North America: Hemostasis and tissue sealing agents Market Share, by Country, 2020
Figure 8 Europe: Hemostasis and tissue sealing agents Market Share, by Country, 2020
Figure 9 Asia-Pacific: Hemostasis and tissue sealing agents Market Share, by Country, 2020
Figure 10 Middle East & Africa: Hemostasis and tissue sealing agents Market Share, by Country, 201
Figure 11 Global Hemostasis and tissue sealing agents Market : Company Share Analysis, 2020 (%)
Figure 12 Johnson & Johnson: Key Financials
Figure 13 Johnson & Johnson: Segmental Revenue
Figure 14 Johnson & Johnson: Geographical Revenue
Figure 15 Cryolife, Inc.: Key Financials
Figure 16 Cryolife, Inc.: Segmental Revenue
Figure 17 Cryolife, Inc.: Geographical Revenue
Figure 18 Baxter International, Inc: Key Financials
Figure 19 Baxter International, Inc: Segmental Revenue
Figure 20 Baxter International, Inc: Geographical Revenue
Figure 21 Biomet Inc: Key Financials
Figure 22 Biomet Inc: Segmental Revenue
Figure 23 Biomet Inc: Geographical Revenue
Figure 24 Integra Lifesciences Corporation: Key Financials
Figure 25 Integra Lifesciences Corporation: Segmental Revenue
Figure 26 Integra Lifesciences Corporation: Geographical Revenue
Figure 27 Becton, Dickinson & Company
Figure 28 Cohera Medical, Inc.
Figure 29 Pfizer, Inc
Figure 30 Medtronic plc
Figure 31 B. Braun Melsungen AG
Figure 32 MIL Laboratories Pvt. Ltd
Figure 33 Advanced Medical Solutions Group Plc
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.